Robin Davison
Recent Quotes
"The central element of ADXN's revised strategy is to advance its clinical-stage candidates."
—
Robin Davison, Edison Investment Research
(3/5/13)
more >
"ADXN's coming phase II studies could catalyze a significant increase in value."
—
Robin Davison, Edison Investment Research
(1/4/12)
more >
"ADXN has the potential to generate high-value product opportunities."
—
Robin Davison, Edison Investment Research
(9/6/11)
more >
"ADXN's new CEO has experience and a strong track record."
—
Robin Davison, Edison Investment Research
(8/16/11)
more >
Due to permission requirements, not all quotes are shown.
